职业经历

Dr. Daniel 的博士学位论文题为“Molecular Characterization of the Hsp70/Hsp90 Organizing Protein (Hop): Phosphorylation, Subcellular Localization and Interaction with Hsp90”。熟悉各种实验室和研究技巧，包括分子生物学技术、器官培养、永生化细胞系 (哺乳动物) 的组织培养、外源蛋白的重组和纯化、重组DNA、荧光共焦显微术、哺乳动物细胞瞬时转染、定点突变、单/双向凝胶电泳、化验、蛋白质印迹、表面等离子体共 振技术、薄层高压液相色谱法 (HPLC) 等。Dr. Daniel从2008年起加入Edanz Editing和理文编辑。

Dr. Daniel’s PhD thesis was “Molecular Characterization of the Hsp70/Hsp90 Organizing Protein (Hop): Phosphorylation, Subcellular Localization and Interaction with Hsp90”. Dr Daniel is familiar with all standard laboratory and research techniques including molecular biological techniques, organ culture, tissue culture of immortalized cell lines (mammalian), recombinant production and purification of heterologous proteins, recombinant DNA manipulation, confocal fluorescent microscopy, transient transfection of mammalian cells, site directed mutagenesis, one and two-dimensional gel electrophoresis, assay techniques, western blot analysis and surface plasmon resonance spectroscopy, thin layer and high pressure liquid chromatography (HPLC). Dr Daniel began as an editor with Edanz Editing and Liwen Bianji (Edanz Editing China) in 2008.

职业经历
Dr. Mosi 的在博士生阶段主要研究糖基转移酶，包括通过使用改良培养基和抑制剂研究糖原磷酸化酶和环糊精糖基转移酶反应机理。Dr. Mosi 曾在制药研究领域里从事八年的高级研究工作。她进行过将金属酶抑制剂用于抗菌药物以及半胱氨酸蛋白酶抑制剂用于癌症治疗等全新研究。Dr. Mosi在酶学、基于受体的细胞生物学、药物新陈代谢、蛋白纯化和培养生产等领域均有所建树。此外，她还设计并规范了译制学术成果的系统和流程，熟知 FDA条款、GLP和GMP规范。Dr. Mosi是Drug Information Association（药品信息协会）、International Society for the Study of Xenobiotics（国际外源物研究学会）、Society for Biomolecular Screening（生物分子筛选学会）、American Society for Microbiology（美国微生物学会）以及 Canadian Society for Chemistry（加拿大化学会）等组织的正式成员。以第一作者的身份发表过10篇同行评审论文，并编辑过生物学、生物化学、化学以及药理学等领域的诸 多文章。目前，Dr. Mosi已经加入到Edanz Editing的编辑团队中。
 
Dr. Mosi’s PhD studies involved the mechanism of reaction of two alpha glycosyltransferases, glycogen phosphorylase and cyclodextrin glycosyltransferase, through the use of modified substrates and inhibitors. Dr. Mosi is a senior research scientist with 8 years experience in pharmaceutical drug research. She has developed and implemented novel assays for the purpose of the identification of inhibitors of metallo-enzymes as antibacterials and inhibitors of cysteine proteases for the treatment of cancer. Dr. Mosi has applied expertise in enzymology, receptor based cell biology, drug metabolism and protein purification and production. As well, she has designed and standardized systems and procedures for interpreting scientific results. She also has a sound knowledge of FDA guidelines and trained in GLP and GMP procedures. Dr. Mosi is a professional member of the Drug Information Association, International Society for the Study of Xenobiotics, Society for Biomolecular Screening, American Society of Microbiology, and the Canadian Society of Chemistry. As first author of 10 published, peer reviewed manuscripts, and as editor of numerous other papers in fields of biology, biochemistry, chemistry and pharmacology Dr. Mosi brings an extensive writing background to her editing work for Edanz Editing.

 
职业经历
多次在职业生涯中获奖，其中包括2003年获得 EU Marie Curie Postdoctoral Fellowship。一直从事帕金森疾病的实验室研究及分子机制和有关亨廷顿舞蹈病的研究。结合激光微解剖，微量检测分析和蛋白质组学。他的研究还涉及在正常衰老进程中所发生的分子变化过程的微阵列基因表达分析，以及这些过程如何受到精神活动的影响。他深入了解神经退化疾病、神经功能、海洋动物学、分子生物学、细胞蛋白质生物化学，包括具有功能基因组和细胞成像的传统与现代技术蛋白质组学的广泛的多学科实验技术。出色的书面和口头表达技巧。2006年初开始为理文编辑工作.
 
Dr. McGowan has won many awards during his career including in 2003 the EU Marie Curie Postdoctoral Fellowship. He has worked in laboratories investigating the molecular mechanisms in Parkinson's disease as well as those involved in Huntington's disease, combining laser micro-dissection, microarray analysis and proteomics. Further study involved micro-array gene expression analysis of molecular processes occurring during normal ageing and how these are affected by mental exercise. Dr. McGowan has an in-depth knowledge of neurodegenerative diseases, neural function, marine zoology, molecular and cellular biology and protein biochemistry, along with extensive multi-disciplinary laboratory experience of contemporary and traditional techniques including proteomics, functional genomics and cell imaging. His excellent written and oral communication skills are demonstrated by several first author publications. From 2005 to October 2006, Dr. McGowan was an Associate Editor at Nature Reviews Neuroscience before becoming a full-time editor for Edanz Editing

职业经历

Dr. Dingley 主要致力于生物化学领域，特别是蛋白质结构和功能特性领域的研究。具有15年以上论文写作以及在有较高影响因子的国际期刊中发表的经验。同时，他也一直在从事科技专书论文的写作，并且担任 Biochemical Journal 的编委。Dr. Dingley 从2008年起为 Edanz Editing 和理文编辑 (Edanz Editing China) 工作。

Dr Dingley’s research is broadly in the area of biochemistry, with particular interest in characterizing protein structure and function. Dr Dingley has over 15 years experience in publishing articles in international high-impact journals. He has written scientific book chapters, and is an editor on the editorial advisory board for the Biochemical Journal. Dr Dingley began as an editor for Edanz Editing and Liwen Bianji (Edanz Editing China) in 2008.

职业经历

Dr. Davies的博士论文题为“The effect of chromatin structure and cisplatin at the human beta-globin gene cluster.”目前在澳大利亚从事助理研究员工作，此前为法国波尔多 Université Bordeaux II 大学 François Magendie Institute for Neuroscience的博士后研究人员。Dr. Davies是几家国际期刊的审稿人，编辑过大量英语母语及非母语作者的稿件。从2006年开始为Edanz Editing工作。他的编辑领域最好通过他具体的实验室工作经验来描述，包括：急性器官型培养、脑片和培养神经细胞的慢病毒操纵及转导、红藻氨酸和碘化丙啶染色、荧光共焦显微技术、活体小鼠模型、蛋白质印迹、电泳凝胶迁移率检测、寡核苷酸设计、染色体DNA提取、DNA人工/自动测序、多种PCR、细菌质粒载体克隆、超速离心分离、蛋白质三维结构计算机模拟分析以及放射物处理等。

Dr. Davies’ PhD was entitled “The effect of chromatin structure and cisplatin at the human beta-globin gene cluster.” Presently a research associate in Australia, Dr. Davies has also been a Postdoctoral Fellow at the François Magendie Institute for Neuroscience, Université Bordeaux II, Bordeaux, France. Dr. Davies is a regular reviewer for several international journals and has edited numerous manuscripts written by both native and non-native English speakers. Dr. Davies began working as an editor for Edanz Editing in 2006. His fields of editing are perhaps best described through details of his laboratory skills, which include: acute and organotypic culture, lentivirus manipulation and transduction of brain slices and cultured neuronal cells, kainate and propidium iodide staining, fluorescent and confocal microscopy, in vivo mouse models, Western blot, electrophoretic gel mobility shift assay, design of oligonucleotides, genomic DNA extraction, DNA sequencing-manual & automated, PCR (most types), cloning into bacterial plasmid vectors, ultracentrifugation, 3D protein computer modeling, radiation handling.

职业经历

Dr. Lodge 是一名细胞生物学家，在学术和制药领域都具有一定的研究经验。博士和博士后就读阶段，他主要研究神经系统发育过程中肌动蛋白细胞骨架和 细胞黏附分子对轴突导向的作用。Dr. Lodge 于2001年加入葛兰素史克 (GlaxoSmithKline) 公司，从事神经变性疾病和精神疾病的目标识别和确认工作，以及干细胞相关的药物研发战略的开发。他具有广泛的细胞生物、分子生物和蛋白质生化技术等方面的专业技能，在国际同行评审期刊上发表过多篇第一作者文章。Dr. Lodge 从2008年起开始为 Edanz Group 工作。

Dr. Lodge is a cell biologist with research experience in both academia and the pharmaceutical industry. For his PhD and postdoctoral work, he studied the roles of the actin cytoskeleton and cell adhesion molecules in axon guidance during nervous system development. Dr. Lodge joined GlaxoSmithKline in 2001, where he has been involved in target identification and validation initiatives for neurodegenerative and psychiatric diseases, and in developing drug discovery strategies involving stem cells. His technical expertise covers a broad spectrum of cell biology, molecular biology and protein biochemistry techniques. Dr. Lodge has published several first author publications in international peer-reviewed journals. He began editing for the Edanz Group in 2008.

职业经历

作为药剂师，Dr. Vocadlo 在生物技术公司从事了六年的药物化学和药品研发工作；曾经参与过化合物多步合成及光谱分析，包括实验设计、操作、化合物的分离、纯化和鉴定等研究工作。Dr. Vocadlo发表过第一作者论文，在科技论文写作和编辑方面经验丰富，2007年开始为Edanz Editing 工作。

编辑领域

应用化学、有机化学、药物化学、药理学和药物研制

编辑领域

分子神经系统科学、生物化学、药理学、帕金森病

职业经历
1997年开始为非英语母语作者的文稿编辑，2004年起为理文编辑工作。其科学研究领域多样化，主要致力于化学 (有机,、有机金属、无机、表面化学)、半导体、生物 (传感器、DNA和蛋白质阵列) 纳米技术。 1996年7月担任东京大学特别研究员，从事新型催化反应途径研究，通过该途径可以在比目前工业应用中更容易实现的条件下生成氨 。现居英国，同时为理文编辑工作，仍活跃在生物纳米传感器的研究中。
 
Dr. Wright has been editing scientific manuscripts for non-native authors since 1997 and has been an editor for Edanz Editing since 2004. His scientific background is diverse with the main scientific fields being in Chemistry (organic, organometallic, inorganic and surface), Semiconductors, Biosensors (transducers, DNA and protein arrays) and Nanotechnology. In 1996/7 Dr. Wright was a Postdoctoral Fellow at The University of Tokyo, Japan, investigating novel catalytic pathways capable of generating ammonia under milder conditions than presently used in industry. As well as working for Edanz editing, Dr. Wright, now based in the UK, continues as a research scientist in the field of bionanosensors.